Cancer52 meets with Minister for Cancer
Interim CEO, Sasha Daly was pleased to meet with Minister Andrew Gwynne to talk through cancer services and how Cancer52 can work in partner
top of page
New CEO for Cancer52!
Cancer52 is delighted to announce the appointment of Chris Walden as our new CEO.
Cancer52 CEO steps down
Longstanding CEO, Jane Lyons stepped down on Monday 15th July. Sasha Daly , Director for Policy at Cancer52, is Interim CEO during the...
Cancer52's Manifesto 'The Other Half'
Cancer52 has launched a manifesto called ‘The Other Half. A manifesto to transform outcomes for people with rare and less common...
Big Cancer52 Conversation, 19th June 2024
Cancer52 recently hosted The Big Cancer52 Conversation at Level39 in Canary Wharf. This was the third Big Cancer52 Conversation, and...
The Ella Dawson Foundation joins Cancer52
The Ella Dawson Foundation is the newest member of Cancer52! The Ella Dawson Foundation provides psychological, emotional, physical,...
NICE Including Technology Appraisal Recommendations in Guideline Topic Areas consultation – Cancer52’s response
Cancer52 submitted a response on the National Institute for Health and Care Excellence (NICE) consultation on proposed changes to...
NICE consultation on Integrated Topic Prioritisation and Strategic Principles – Cancer52’s response
In April 2024, Cancer52 submitted a response on National Institute for Health and Care Excellence (NICE) consultation on its new approach...
Consultation on Working Alongside People and Communities at NICE – Cancer52’s response
National Institute for Health and Care Excellence (NICE) consulted on a new Working alongside people and communities at NICE: a...
Role of Incentive Schemes in General Practice consultation – Cancer52’s response
The Department of Health and Social Care (DHSC) held a consultation on the role of incentive schemes in general practice in...
bottom of page